Literature DB >> 6705765

Cell-free synthesis of Schistosoma mansoni surface antigens: stage specificity of their expression.

M Knight, A J Simpson, G Payares, M Chaudri, S R Smithers.   

Abstract

Messenger RNA has been extracted from all stages of the life cycle of the parasitic multicellular helminth Schistosoma mansoni. In vitro translation of these mRNA preparations in rabbit reticulocyte lysates yielded in each case a large number of polypeptides. Immunoprecipitation of translation products either by serum from immune mice or from human patients demonstrated that relatively few, approximately 10, polypeptides are recognised as antigens. Two of the in vitro synthesised antigens, of mol. wts. 22 000 and 14 000, were demonstrated to correspond to schistosomula surface antigens. The expression of these antigens may show stage specificity. Both are readily detected from adult and sporocyst translation products, neither from schistosomula and only the 22 000 antigen from miracidia. This is an unexpected finding since similar polypeptide antigens occur on the surface of schistosomula. These results indicate that not only are schistosomula surface antigens preformed at the preceding sporocyst stage, i.e., within the snail host, but they also remain invariant throughout the life cycle in the vertebrate host. Two other prominent schistosomula surface antigens of mol. wts. 38 000 and 32 000, were not recognised amongst cell-free translation products directed by RNA from any life cycle stage. The demonstration that at least two schistosomula surface antigens are detectable amongst adult mRNA cell-free translation products demonstrates the feasibility of identifying the genes encoding them in cDNA libraries from adult worm mRNA.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6705765      PMCID: PMC557322          DOI: 10.1002/j.1460-2075.1984.tb01786.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  16 in total

1.  Schistosoma mansoni: defined system for stepwise transformation of cercaria to schistosomule in vitro.

Authors:  F J Ramalho-Pinto; G Gazzinelli; R E Howells; T A Mota-Santos; E A Figueiredo; J Pellegrino
Journal:  Exp Parasitol       Date:  1974-12       Impact factor: 2.011

2.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

3.  An efficient mRNA-dependent translation system from reticulocyte lysates.

Authors:  H R Pelham; R J Jackson
Journal:  Eur J Biochem       Date:  1976-08-01

4.  Isolation and partial characterization of the tegumental outer membrane of adult Schistosoma mansoni.

Authors:  A J Simpson; M D Schryer; I M Cesari; W H Evans; S R Smithers
Journal:  Parasitology       Date:  1981-08       Impact factor: 3.234

5.  Immunization of mice with cobalt-60 irradiated Schistosoma mansoni cercariae.

Authors:  P Minard; D A Dean; R H Jacobson; W E Vannier; K D Murrell
Journal:  Am J Trop Med Hyg       Date:  1978-01       Impact factor: 2.345

6.  Surface antigens of Schistosoma mansoni.

Authors:  D W Taylor; E G Hayunga; W E Vannier
Journal:  Mol Biochem Parasitol       Date:  1981-07       Impact factor: 1.759

Review 7.  The immunology of schistosomiasis.

Authors:  S R Smithers; R J Terry
Journal:  Adv Parasitol       Date:  1969       Impact factor: 3.870

8.  Immunization of rhesus monkeys against schistosome infection by cercariae exposed to high doses of x-radiation.

Authors:  S Y Hsü; H F Hsü; J W Osborn
Journal:  Proc Soc Exp Biol Med       Date:  1969-09

9.  Observations on cattle schistosomiasis in the Sudan, a study in comparative medicine. III. Field testing of an irradiated Schistosoma bovis vaccine.

Authors:  A A Majid; H O Bushara; A M Saad; M F Hussein; M G Taylor; J D Dargie; T F Marshall; G S Nelson
Journal:  Am J Trop Med Hyg       Date:  1980-05       Impact factor: 2.345

10.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

View more
  7 in total

1.  Protection against experimental Schistosoma mansoni schistosomiasis achieved by immunization with schistosomula released products antigens (SRP-A): role of IgE antibodies.

Authors:  M Damonneville; C Auriault; C Verwaerde; A Delanoye; R Pierce; A Capron
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

2.  Human immunoglobulin E responses to a recombinant 22.6-kilodalton antigen from Schistosoma mansoni adult worms are associated with low intensities of reinfection after treatment.

Authors:  M Webster; A J Fulford; G Braun; J H Ouma; H C Kariuki; J C Havercroft; K Gachuhi; R F Sturrock; A E Butterworth; D W Dunne
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

3.  Characterization of a female-specific cDNA derived from a developmentally regulated mRNA in the human blood fluke Schistosoma mansoni.

Authors:  L Bobek; D M Rekosh; H van Keulen; P T LoVerde
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  Isolation of cDNA clones for differentially expressed genes of the human parasite Schistosoma mansoni.

Authors:  A H Davis; R Blanton; F Rottman; R Maurer; A Mahmoud
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

Review 5.  Progress in molecular parasitology.

Authors:  P Köhler
Journal:  Experientia       Date:  1986-04-15

6.  Comparison of the in vitro translation capacity of Taenia crassiceps metacestode mRNA prepared by the phenol and cesium chloride method.

Authors:  R Kleine-Herzbruch; E Geyer
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

7.  A cDNA clone encoding part of the major 25,000-dalton surface membrane antigen of adult Schistosoma mansoni.

Authors:  M Knight; C Kelly; V Rodrigues; X Yi; A Wamachi; S R Smithers; A J Simpson
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.